₹331.7
-1.65% today
· 30d +0.73%
as of 2026-11-09
Price · Daily Candles
“INDRAMEDCO: Q4 Profit Growth Slows Amidst Broader Downtrend, Analyst Target Undimmed.”
INDRAMEDCO, with a market cap of ₹3407.0 Cr, saw quarterly profit growth slow to +1.68% YoY despite a +9.31% YoY revenue increase for Q4 2026. The stock trades at a TTM PE of 18.55, significantly below the sector average, and has declined 29.55% over the last six months, approaching its 52-week low.
BULL CASE
+Annual net profit grew by 14.06% YoY to ₹184.0 Cr in FY26, following a 5-year CAGR of 139.52%.
+Trading at a TTM P/E of 18.55, INDRAMEDCO is considerably cheaper than sector peers like APOLLOHOSP (PE 82.13) and MAXHEALTH (PE 67.07).
+Profitability is strong, with a profit margin of 12.39% and a current FCF yield of 3.16%.
+Despite recent price weakness, the sole analyst covering the stock has a mean target of ₹550.0, implying significant upside from the current price of ₹375.0, with zero target dispersion.
BEAR CASE
−Q4 2026 net profit growth significantly decelerated to 1.68% YoY, even as operating profit growth stalled at 0.25% YoY.
−The stock has seen substantial price depreciation, down 29.55% over the last six months and is only 9.65% above its 52-week low of ₹342.0.
−FII shareholding decreased by 0.29% QoQ to 2.44% in Q4 2026.
−Technical indicators are bearish, with a moderate bearish MACD signal and the stock trading near its 52-week low.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹413 Cr
+8.35% YoY
NET PROFIT
₹54 Cr
+8.33% YoY
OPM
20.41%
+0.15pp YoY
EPS
₹5.84
PE 18.55
Intrinsic value · DCF ₹54.96 · Margin of safety -83.4% (overvalued) · FCF yield 3.58%
◇ Sector Position
INDRAMEDCO's TTM PE of 18.55 is substantially lower than most peers like APOLLOHOSP (82.13) and MAXHEALTH (67.07), but its ROCE of 14.44% lags behind ASTERDM's 103.54% and NH's 22.72%.
PEERPEROCE %
INDRAMEDCO18.55—
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
52
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
UNDERPERFORMER
5
Valuation
CHEAP
75
Growth
STEADY
59
Profitability
HIGH
75
Technicals
WEAK
47
Risk
MODERATE
50
Key Stats
TTM PE
18.55
P/B
5.17
52W HIGH
₹640.85
OFF HIGH
-48.24%
DIV YIELD
1.24%
MKT CAP
₹3014 Cr
◉ Active Signals
MACDNeutral4.2473
RSI(14)Neutral52.63
Street Consensus
1 analyst₹550.0
mean target
Low ₹550.0Now ₹331.7High ₹550.0
⧉ Strategy Fit 🔒